0001209191-13-041574.txt : 20130820 0001209191-13-041574.hdr.sgml : 20130820 20130820171826 ACCESSION NUMBER: 0001209191-13-041574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160816 FILED AS OF DATE: 20130820 DATE AS OF CHANGE: 20130820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC CENTRAL INDEX KEY: 0001008848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 BUSINESS PHONE: 914-347-4300 MAIL ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COHEN RON CENTRAL INDEX KEY: 0001272354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50513 FILM NUMBER: 131051394 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-16 0 0001008848 ACORDA THERAPEUTICS INC ACOR 0001272354 COHEN RON 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 0 1 0 0 President and CEO Common Stock 2013-08-16 4 M 0 19000 2.60 A 357090 D Common Stock 2013-08-16 4 M 0 42062 2.60 A 399152 D Common Stock 2013-08-16 4 S 0 61062 34.04 D 338090 D Common Stock 2013-08-19 4 M 0 55993 2.60 A 394083 D Common Stock 2013-08-19 4 S 0 55993 34.02 D 338090 D Common Stock 2013-08-20 4 M 0 31945 2.60 A 370035 D Common Stock 2013-08-20 4 S 0 26105 34.25 D 343930 D Common Stock 2013-08-20 4 S 0 5840 34.82 D 338090 D Common Stock 2013-08-20 4 M 0 19461 2.60 A 357551 D Common Stock 2013-08-20 4 M 0 113141 2.60 A 470692 D Common Stock 2013-08-20 4 M 0 8176 2.60 A 478868 D Employee Stock Option (right to buy) 2.60 2013-08-16 4 M 0 19000 0.00 D 2013-10-17 Common Stock 19000 19461 D Employee Stock Option (right to buy) 2.60 2013-08-16 4 M 0 42062 0.00 D 2013-09-11 Common Stock 42062 201079 D Employee Stock Option (right to buy) 2.60 2013-08-19 4 M 0 55993 0.00 D 2013-09-11 Common Stock 55993 145086 D Employee Stock Option (right to buy) 2.60 2013-08-20 4 M 0 31945 0.00 D 2013-09-11 Common Stock 31945 113141 D Employee Stock Option (right to buy) 2.60 2013-08-20 4 M 0 19461 0.00 D 2013-10-17 Common Stock 19461 0 D Employee Stock Option (right to buy) 2.60 2013-08-20 4 M 0 113141 0.00 D 2013-09-11 Common Stock 113141 0 D Employee Stock Option (right to buy) 2.60 2013-08-20 4 M 0 8176 0.00 D 2013-09-11 Common Stock 8176 0 D The stock options listed on Table I, Column 4 and Table II, Column 1 are being exercised because all of these options would otherwise expire in September and October of this year. A total of 149,000 of the 289,778 shares issued upon exercise of these options have been sold, the proceeds of which are being used to fund the exercise of these options and the resulting tax liability. The sales referred to in Table I, Column 4 were made pursuant to a 10b5-1 plan. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.73 to $34.44 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.56 to $34.54 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.77 to $34.77 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $34.79 to $34.86 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The shares subject to these options vested in installments and were fully vested on April 17, 2005. The shares subject to these options vested in installments and were fully vested on March 31, 2005. /s/ Ron Cohen 2013-08-20